European journal of nuclear medicine and molecular imaging 48(13), 4525-4531 (2021). doi:10.1007/s00259-021-05549-z European journal of nuclear medicine and molecular imaging 48(7), 2070-2085 (2021). doi:10.1007/s00259-020-05120-2 European Journal of Nuclear Medicine and Molecular Imaging, 48(7), 2070-2085. Springer Verlag European journal of nuclear medicine and molecular imaging, vol 48, iss 7 European Journal of Nuclear Medicine and Molecular Imaging Boccardi, M, Dodich, A, Albanese, E, Gayet-Ageron, A, Festari, C, Ashton, N J, Bischof, G R N, Chiotis, K, Leuzy, A, Wolters, E E, Walter, M A, Rabinovici, G D, Carrillo, M, Drzezga, A, Hansson, O, Nordberg, A, Ossenkoppele, R, Villemagne, V L, Winblad, B, Frisoni, G B & Garibotto, V 2021, ' The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 7, pp. 2070-2085 . https://doi.org/10.1007/s00259-020-05120-2 European Journal of Nuclear Medicine and Molecular Imaging (2021)
European journal of nuclear medicine and molecular imaging 48(7), 2110-2120 (2021). doi:10.1007/s00259-020-05156-4 Bischof, G R N, Dodich, A, Boccardi, M, van Eimeren, T, Festari, C, Barthel, H, Hansson, O, Nordberg, A, Ossenkoppele, R, Sabri, O, Giovanni, B F G, Garibotto, V & Drzezga, A 2021, ' Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 7, pp. 2110-2120 . https://doi.org/10.1007/s00259-020-05156-4 European Journal of Nuclear Medicine and Molecular Imaging